Chronic Kidney Disease Market Report 2019 | Global Size, Historical Analysis, Emerging Trends, Future Scope, Opportunities and Forecast to 2023

Chronic Kidney Disease Market Report 2019 | Global Size, Historical Analysis, Emerging Trends, Future Scope, Opportunities and Forecast to 2023

“Latest Analysis On Chronic Kidney Disease Market”
Chronic Kidney Disease Market Research Report: By Diagnosis (Blood Test, Urine Test, Biopsy), by Treatment (Drugs, Dialysis, Kidney Transplant), by Indication (Type 1 or Type 2 Diabetes, High Blood Pressure), End-User (Hospitals) – Global Forecast Till 2023

Market Synopsis:

Market Research Future (MRFR)’s latest study reveals that the global chronic kidney disease market is set to expand moderately at a CAGR of 5.2% during the forecast period 2017 to 2023. The investments into development of new treatments coupled with rising prevalence of kidney diseases are expected to drive the growth of the market in the next couple of years. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the U.S., has stated that nearly 14% of the overall population is affected by chronic kidney diseases. 

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5744

An upsurge in the number of biopsy procedures is witnessed in the recent times and is likely to perpetuate in the forthcoming years. This, in turn, is expected to have a positive influence on the proliferation of the chronic kidney disease market. Furthermore, the rising burden of diabetes has intensified the preventive care treatment for kidney diseases. It is anticipated to have a strong impact on the growth of the market. Other factors responsible for the growth of the market are rising healthcare expenditure, developing healthcare sector, growing research & development activities, technological advancements in the healthcare sector, etc.

 

Key Players 

  • Abbott, Siemens
  • Sysmex
  • Beckman Coulter
  • F. Hoffmann-La Roche Ltd
  • ACON Laboratories
  • URIT Medical
  • Nova Biomedical
  • ARKRAY
  • OPTI Medical
  • 77 Elektronika
  • Randox Laboratories
  • Teva Pharmaceutical Industries Ltd
  • Amgen
  • AstraZeneca
  • Pfizer
  • F. Hoffmann-La Roche Ltd
  • Sanofi S.A.
  • GlaxoSmithKline
  • AbbVie
  • Kissei Pharmaceutical 

Segmentation

The global chronic kidney disease market is segmented on the basis of diagnosis, treatment, indication, and end-user.

On the basis of diagnosis, it is segmented into blood test, urine test, imaging test, and kidney biopsy.

On the basis of treatment, it is segmented into drugs, dialysis, and kidney transplant. Drugs are further segmented into ace inhibitors, angiotensin-ii receptor blockers, calcium channel blockers, beta-blockers, and erythropoiesis-stimulating agents.

Based on indication, it is segmented into Type 1 or Type 2 diabetes, high blood pressure, polycystic kidney disease, and others.

Based on end-user, it is segmented into hospitals and clinics, diagnostic centers, and others.

Regional Analysis:

By region, the global chronic kidney disease market has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas is poised to exhibit a healthy growth throughout the forecast period. The growth is attributable to the increasing patient pool, rising demand for alternative treatments, extensive use of diagnostic tests, etc.

Europe is an important growth pocket of the chronic kidney disease market. The factors responsible for favoring the expansion of the regional market include rising awareness about risk factors associated with kidney diseases, booming medical device industry, exponential diabetic population, huge investments in the medical device sector, etc. Additionally, rising government support and funding for research & development is further likely to augment the regional chronic kidney disease market over the assessment period. 

For Discount You Can Visit @ https://www.marketresearchfuture.com/check-discount/5744

Asia Pacific is projected to strike a relatively higher CAGR owing to the large-scale prevalence of diabetes and cardiovascular diseases. The growth of the region can be ascribed to the presence of developed healthcare infrastructure, rapid advancements in the healthcare sector, the presence of skilled healthcare professionals, etc.

The Middle East & Africa accounts for the least share of the chronic kidney disease market. It is due to the limited technological penetration and lack of awareness. 

Table Of Content 

1. Report Prologue

2. Market Introduction

3. Research Methodology

5. Market Factor Analysis

6. Global Chronic Kidney Disease Market, By Diagnosis

….. 

Read Complete Report @ https://www.marketresearchfuture.com/reports/chronic-kidney-disease-market-5744

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/chronic-kidney-disease-market-5744